Don't know why you can't remember the dreams while your wife can recall most of those?
The reason for dreaming is still a mystery, but scientists have now found out the differences between the 'high-dream recallers' - who recall dreams regularly - and 'low-dream recallers' who recall dreams rarely.
The secret lies at the temporo-parietal junction of the brain - an information-processing hub - which is more active in high dream recallers.
"Increased activity in this brain region might facilitate attention orienting toward external stimuli and promote intra-sleep wakefulness, thereby facilitating the encoding of dreams in memory," said the study by Perrine Ruby a research fellow at the Lyon Neuroscience Research Centre in France.
The high-dream recallers also awaken more frequently in their sleep than low-dream recallers.
"The sleeping brain is not capable of memorising new information; it needs to awaken to be able to do that," explained Ruby.
High-dream recallers, both while awake and while asleep, showed stronger spontaneous brain activity in the medial prefrontal cortex (mPFC) and in the temporo-parietal junction (TPJ) - an area of the brain involved in attention orienting toward external stimuli.
This may explain why high-dream recallers are more reactive to environmental stimuli, awaken more during sleep, and thus better encode dreams in memory than low-dream recallers, said the study.
The researchers used Positron Emission Tomography (PET), an imaging technique that uses a radioactive substance, to measure the spontaneous brain activity of 41 volunteers during wakefulness and sleep.
The volunteers were classified into two groups: 21 high-dream recallers who recalled dreams 5.2 mornings per week in average, and 20 low-dream recallers who reported 2 dreams per month in average.
The findings suggest that high and low-dream recallers differ in dream memorisation but do not exclude that they also differ in dream production.
It is possible that high-dream recallers produce a larger amount of dreaming than low dream recallers, added the study published in the journal Neuropsychopharmacology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
